The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating racial inequities of circulating tumor DNA (ctDNA) use in patients with non-small cell lung cancer: A real world analysis.
 
Angelica D'Aiello
No Relationships to Disclose
 
Hiba Narvel
No Relationships to Disclose
 
Ayse Ece Cali Daylan
No Relationships to Disclose
 
Eleftheria Atalla
No Relationships to Disclose
 
Sindhu Vikash
No Relationships to Disclose
 
Sheila Solomon
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Haiying Cheng
No Relationships to Disclose
 
Jianyou Liu
No Relationships to Disclose
 
Xiaonan Xue
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; Arcus Biosciences; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Merck; Novartis; Pfizer; Takeda; Turning Point Therapeutics; Veracyte
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)